Hsing-Hui Su

Hsing-Hui Su

Auto-generated profile, based on publicly available information

Hsing-Hui Su

Department of Pharmacology and Institute of Medicine, Chung Shan Medical University, No. 110, Sec. 1, Jianguo North Rd., Taichung 402, Taiwan; Department of Medical Laboratory and Biotechnology, Chung Shan Medical University, No. 110, Sec. 1, Jianguo North Rd., Taichung 402, Taiwan

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2019 in Basic Research in Cardiology
Verified
Journal Article
Closed access
PDF file
HSHsing-Hui Su
Hsing-Hui Su
JLJiuan-Miaw Liao
Jiuan-Miaw Liao
YWYi-Hsin Wang
Yi-Hsin Wang
KCKe-Min Chen
Ke-Min Chen
CLChia-Wei Lin
Chia-Wei Lin
SHShiang-Suo Huang
Shiang-Suo Huang

1 August 2008 in Life Sciences
Verified
Journal Article
Closed access
JLJeng-Feng Lin
Jeng-Feng Lin
SLSu-Man Lin
Su-Man Lin
CCChun-Lien Chih
Chun-Lien Chih
MNMao-Wei Nien
Mao-Wei Nien
HSHsin-Hui Su
Hsin-Hui Su
STShen-Kou Tsai
Shen-Kou Tsai

1 October 2016 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
YWYi-Hsin Wang
Yi-Hsin Wang
KCKe-Min Chen
Ke-Min Chen
PCPing-Sung Chiu
Ping-Sung Chiu
SLShih-Chan Lai
Shih-Chan Lai
HSHsing-Hui Su
Hsing-Hui Su
SHShiang-Suo Huang
Shiang-Suo Huang

15 June 2018 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
YWYi-Hsin Wang
Yi-Hsin Wang
SLShun-An Li
Shun-An Li
CHChao-Hsin Huang
Chao-Hsin Huang
HSHsing-Hui Su
Hsing-Hui Su
YCYi-Hung Chen
Yi-Hung Chen
SHShiang-Suo Huang
Shiang-Suo Huang
Lumbrokinase is used as an oral supplement to support and maintain healthy cardiovascular function, and to treat cardiovascular diseases in clinical for more than 10 years. Up until now, the mechanism of the cardioprotective effects of post-ischemic treatment with lumbrokinase has remained unclear. We therefore investigated the signaling pathways involved in the amelioration of myocardial ischemia-reperfusion (I-R) injury in rats treated with lumbrokinase 20 min after myocardial ischemia. Compared to vehicle-treated rats, post-ischemic treatment with lumbrokinase was associated with significant reductions in myocardial I-R-induced arrhythmias and myocardial damage, and an improvement in cardiac function. Moreover, lumbrokinase significantly upregulated levels of silent information regulator 1 (Sirt1). In addition, lumbrokinase significantly increased manganese-dependent superoxide dismutase expression, decreased Cleaved-Caspase-3 expression, and induced deacetylation of FoxO1. On the other hand, lumbrokinase also significantly downregulated levels of succinate dehydrogenase, cytochrome c oxidase, nuclear factor kappa B (NF-κB) and elevated levels of microtubule-associated protein light chain 3. Notably, the cardioprotective effects of lumbrokinase were abolished by administration of the specific Sirt1 inhibitor EX527. These findings demonstrate that post-ischemic treatment with lumbrokinase attenuates myocardial I-R injury through the activation of Sirt1 signaling, and thus enhances autophagic flux and reduces I-R-induced oxidative damage, inflammation and apoptosis.

4 April 2017 in Frontiers in Pharmacology
Verified
Journal Article
Open access
HSHsing-Hui Su
Hsing-Hui Su
YCYa-Chun Chu
Ya-Chun Chu
JLJiuan-Miaw Liao
Jiuan-Miaw Liao
YWYi-Hsin Wang
Yi-Hsin Wang
MJMing-Shiou Jan
Ming-Shiou Jan
SHShiang-Suo Huang
Shiang-Suo Huang
The incidence of myocardial ischemia-reperfusion (IR) injury is rapidly increasing around the world and this disease is a major contributor to global morbidity and mortality. It is known that regulation of programmed cell death including apoptosis and autophagy reduces the impact of myocardial IR injury. In this study, the cardioprotective effects and underlying mechanisms of Phellinus linteus (Berk. & Curt.) Teng, Hymenochaetaceae (PL), a type of medicinal mushroom, were examined in rats subjected to myocardial IR injury. The left main coronary artery of rats was ligated for 1 h and reperfused for 3 h. The arrhythmia levels were monitored during the entire process and the infarct size was evaluated after myocardial IR injury. Furthermore, the expression levels of proteins in apoptotic and autophagic pathways were observed. Pretreatment with PL mycelium (PLM) significantly reduced ventricular arrhythmia and mortality due to myocardial IR injury. PLM also significantly decreased myocardial infarct size and plasma lactate dehydrogenase level after myocardial IR injury. Moreover, PLM administration resulted in decreased caspase 3 and caspase 9 activation and Bcl-2/Bax ratio. Phosphorylation level of AMPK was elevated while mTOR level was reduced. Becline-1 and p62 levels decreased. These findings suggest that PLM is effective in protecting the myocardium against IR injury. The mechanism involves mediation through suppressed pro-apoptotic signaling and regulation of autophagic signaling, including stimulation of AMPK-dependent pathway and inhibition of beclin-1-dependent pathway, resulting in enhancement of protective autophagy and inhibition of excessive autophagy.

Verified
Journal Article
Open access
PDF file
CTChin-Feng Tsai
Chin-Feng Tsai
HLHui-Wen Lin
Hui-Wen Lin
JLJiuan-Miaw Liao
Jiuan-Miaw Liao
KCKe-min Chen
Ke-min Chen
JTJen-Wei Tsai
Jen-Wei Tsai
SHShiang-Suo Huang
Shiang-Suo Huang
Myocardial ischemia/reperfusion (I/R) injury is marked by rapid increase in inflammation and not only results in myocardial apoptosis but also compromises the myocardial function. Dunaliella salina (D. salina), a halophilic unicellular microalga, has been used as a provitamin A carotenoid supplement and color additive. Several studies have reported that D. salina extract could attenuate lipopolysaccharides-induced inflammatory effects and regulate the virus-induced inflammatory response in macrophages. However, the effects of D. salina on myocardial I/R injury remain unknown. Therefore, we aimed to investigate the cardioprotection of D. salina extract in rats subjected to myocardial I/R injury that was induced by occlusion of the left anterior descending coronary artery for 1 h followed by 3 h of reperfusion. Compared with the vehicle group, the myocardial infarct size significantly decreased in rats that were pre-treated with D. salina. D. salina significantly attenuated the expressions of TLR4, COX-2 and the activity of STAT1, JAK2, IκB, NF-κB. Furthermore, D. salina significantly inhibited the activation of caspase-3 and the levels of Beclin-1, p62, LC3-I/II. This study is the first to report that the cardioprotective effects of D. salina may mediate anti-inflammatory and anti-apoptotic activities and decrease autophagy through the TLR4-mediated signaling pathway to antagonize myocardial I/R injury.